DOI: 10.36347/sjmcr.2021.v09i05.030

Pages: 568-572

Allergic conjunctivitis represents one of the most frequently encountered pathologies in daily ophthalmological practice, but despite the evolution of knowledge, its therapeutic management differs according to the practitioners, the aim of our work is to compare four therapeutic protocols in terms of efficiency. Thus, we carried out a prospective study concerning 120 patients followed up for minimal to moderate allergic conjunctivitis, during 08 months, the follow-up made thanks to the scores which we established. For the analysis we were based on adapted statistical tests (SPSS 17.0) the four protocols all by local route are: A (artificial tears), B (antihistamines), C (mast cell anti-granulants) and D (antihistamines associated with anti-granulants). At the end of the work, the four treatment protocols were compared, group D seems the most effective followed by group C then B and last A, 87.5% of patients adhered well to the instructions, in 6.66% a change in protocol was the rule. Minimal to moderate allergic conjunctivitis is a common pathology but too often ignored and untreated, if not on an ad hoc basis. Several studies have shown different results depending on the molecule chosen. Towards a single consensus for the management of allergic conjunctivitis, there is still a way to go. Conclusion to treat allergic conjunctivitis is to prevent chronicization and to confer better well-being on the patient. The antihistamine and anti-granulating combination seems to be one of the most encouraging protocols.